Numerical Algebra, Control and Optimization

American Institute of Mathematical Sciences (AIMS)
American Institute of Mathematical Sciences (AIMS)
ISSN: 21553289, 21553297

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
SCImago
Q3
WOS
Q2
Impact factor
1.1
SJR
0.385
CiteScore
3.1
Categories
Algebra and Number Theory
Applied Mathematics
Control and Optimization
Areas
Mathematics
Years of issue
2011-2025
journal names
Numerical Algebra, Control and Optimization
NUMER ALGEBR CONTROL
Publications
582
Citations
2 686
h-index
25
Top-3 organizations
Curtin University
Curtin University (14 publications)
University Putra Malaysia
University Putra Malaysia (11 publications)
Top-3 countries
China (154 publications)
USA (67 publications)
Iran (35 publications)

Most cited in 5 years

Found 
from chars
Publications found: 1701
Oral Mucositis in Head and Neck Cancer Patients
Anderson C., Saunders D.
Q1
Elsevier
Seminars in Radiation Oncology 2025 citations by CoLab: 0
The Future of Head and Neck Radiotherapy: Not Your Father's Three-Field
Sher D.J., Mowery Y.M.
Q1
Elsevier
Seminars in Radiation Oncology 2025 citations by CoLab: 0
Reirradiation for Locally Recurrent Head and Neck Cancer: State-of-the-Art and Future Directions
Phan J., Spiotto M.T., Goodman C.D., Reddy J., Newcomm P., Garden A.S., Lee A.
Q1
Elsevier
Seminars in Radiation Oncology 2025 citations by CoLab: 0
Predictors of Radiation Resistance and Novel Radiation Sensitizers in Head and Neck Cancers: Advancing Radiotherapy Efficacy
Sobti A., Skinner H., Wilke C.T.
Q1
Elsevier
Seminars in Radiation Oncology 2025 citations by CoLab: 0
Head and Neck Cancer of Unknown Primary: A Surgical Perspective
Chow M.S., Duvvuri U.
Q1
Elsevier
Seminars in Radiation Oncology 2025 citations by CoLab: 0
Immunotherapy With Curative Intent Radiotherapy for Patients With Cancers of the Head and Neck
Hill J., Schoenfeld J.D.
Q1
Elsevier
Seminars in Radiation Oncology 2025 citations by CoLab: 0
De-escalation of Adjuvant Therapy in Operatively Managed HPV Associated Oropharyngeal Carcinoma: Current Status and Future Directions
Ma D., Routman D.M.
Q1
Elsevier
Seminars in Radiation Oncology 2025 citations by CoLab: 0
Managing Patients with Head and Neck Cancer and Advanced Age or Comorbidities
Price J.M., Mell L.K.
Q1
Elsevier
Seminars in Radiation Oncology 2025 citations by CoLab: 0
Metastatic Head and Neck Cancer: Immunotherapy and Beyond
Nguyen K.V., Lee C.M., Choe J.H.
Q1
Elsevier
Seminars in Radiation Oncology 2025 citations by CoLab: 0
Novel Survivorship Paradigms in Head/Neck Cancer
Armache M., Larson A., Stemme R., Walsh-Bailey C., Scott K., Pearman T., Stepan K.O., Mierzwa M.L., Mady L.J., Gharzai L.A.
Q1
Elsevier
Seminars in Radiation Oncology 2025 citations by CoLab: 0
De-escalated Management of HPV-positive Oropharyngeal Carcinoma: Improving Outcomes with Personalized Approaches
Yacoub I., Shamseddine A., Qian J., Youssef M., Safavi A.H., Lee N.Y.
Q1
Elsevier
Seminars in Radiation Oncology 2025 citations by CoLab: 0
Radiation-Therapy Related Salivary Dysfunction
Blitzer G.C., Paz C., McCoy S.S., Kimple R.J.
Q1
Elsevier
Seminars in Radiation Oncology 2025 citations by CoLab: 0
Personalising Nasopharyngeal Cancer: Systemic Therapy and Radiotherapy Treatment Volumes
Huang B.X., Zhang X., Kang M.P., Chua M.L.
Q1
Elsevier
Seminars in Radiation Oncology 2025 citations by CoLab: 0
Hypofractionated Radiation Therapy in the Definitive Management of Head and Neck Cancer
Moon D.H., Awan M.J.
Q1
Elsevier
Seminars in Radiation Oncology 2025 citations by CoLab: 0
Principles and Paradigms of De-Escalated Elective Nodal Irradiation: Boldly Going Towards an Inflection Point in Head and Neck Radiotherapy
Safavi A.H., Lee N.Y., Tsai C.J.
Q1
Elsevier
Seminars in Radiation Oncology 2025 citations by CoLab: 0

Top-100

Citing journals

10
20
30
40
50
60
70
80
Show all (70 more)
10
20
30
40
50
60
70
80

Citing publishers

100
200
300
400
500
600
700
800
Show all (49 more)
100
200
300
400
500
600
700
800

Publishing organizations

2
4
6
8
10
12
14
Show all (70 more)
2
4
6
8
10
12
14

Publishing organizations in 5 years

1
2
3
4
5
Show all (70 more)
1
2
3
4
5

Publishing countries

20
40
60
80
100
120
140
160
China, 154, 26.46%
USA, 67, 11.51%
Iran, 35, 6.01%
Australia, 29, 4.98%
Germany, 27, 4.64%
India, 27, 4.64%
Malaysia, 24, 4.12%
Japan, 21, 3.61%
France, 16, 2.75%
Russia, 12, 2.06%
United Kingdom, 12, 2.06%
Algeria, 11, 1.89%
Morocco, 9, 1.55%
Republic of Korea, 9, 1.55%
Turkey, 9, 1.55%
Nigeria, 7, 1.2%
South Africa, 7, 1.2%
Canada, 6, 1.03%
Egypt, 5, 0.86%
Poland, 5, 0.86%
Bangladesh, 4, 0.69%
Belgium, 4, 0.69%
Vietnam, 4, 0.69%
Israel, 4, 0.69%
Portugal, 3, 0.52%
Brazil, 3, 0.52%
Italy, 3, 0.52%
Mongolia, 3, 0.52%
Netherlands, 3, 0.52%
Saudi Arabia, 3, 0.52%
Thailand, 3, 0.52%
Sweden, 3, 0.52%
Austria, 2, 0.34%
Hungary, 2, 0.34%
Greece, 2, 0.34%
Iraq, 2, 0.34%
New Zealand, 2, 0.34%
Pakistan, 2, 0.34%
Uzbekistan, 2, 0.34%
Czech Republic, 2, 0.34%
Zimbabwe, 1, 0.17%
Ireland, 1, 0.17%
Spain, 1, 0.17%
Cape Verde, 1, 0.17%
Colombia, 1, 0.17%
UAE, 1, 0.17%
Reunion, 1, 0.17%
Romania, 1, 0.17%
Singapore, 1, 0.17%
Slovakia, 1, 0.17%
Uruguay, 1, 0.17%
Croatia, 1, 0.17%
Chile, 1, 0.17%
Ecuador, 1, 0.17%
Eswatini, 1, 0.17%
Show all (25 more)
20
40
60
80
100
120
140
160

Publishing countries in 5 years

5
10
15
20
25
30
35
40
45
China, 41, 16.94%
USA, 39, 16.12%
India, 18, 7.44%
Iran, 13, 5.37%
France, 11, 4.55%
Algeria, 10, 4.13%
United Kingdom, 8, 3.31%
Morocco, 8, 3.31%
Nigeria, 6, 2.48%
South Africa, 6, 2.48%
Turkey, 5, 2.07%
Japan, 4, 1.65%
Germany, 3, 1.24%
Vietnam, 3, 1.24%
Canada, 3, 1.24%
Thailand, 3, 1.24%
Australia, 2, 0.83%
Bangladesh, 2, 0.83%
Brazil, 2, 0.83%
Egypt, 2, 0.83%
Iraq, 2, 0.83%
Poland, 2, 0.83%
Russia, 1, 0.41%
Austria, 1, 0.41%
Greece, 1, 0.41%
Zimbabwe, 1, 0.41%
Israel, 1, 0.41%
Ireland, 1, 0.41%
Colombia, 1, 0.41%
Mongolia, 1, 0.41%
New Zealand, 1, 0.41%
UAE, 1, 0.41%
Pakistan, 1, 0.41%
Republic of Korea, 1, 0.41%
Romania, 1, 0.41%
Saudi Arabia, 1, 0.41%
Uruguay, 1, 0.41%
Croatia, 1, 0.41%
Czech Republic, 1, 0.41%
Sweden, 1, 0.41%
Eswatini, 1, 0.41%
Show all (11 more)
5
10
15
20
25
30
35
40
45